Mumbai, India: Fischer Medical Ventures Limited (FMVL) today announced that its strategic partner, Nanyang Biologics, has achieved a significant international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by